- Home
- LEO vs NPCE Comparison
LEO vs NPCE Comparison
Compare LEO & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEO
- NPCE
- Stock Information
- Founded
- LEO 1987
- NPCE 1997
- Country
- LEO United States
- NPCE United States
- Employees
- LEO N/A
- NPCE N/A
- Industry
- LEO Trusts Except Educational Religious and Charitable
- NPCE Medical Specialities
- Sector
- LEO Finance
- NPCE Health Care
- Exchange
- LEO Nasdaq
- NPCE Nasdaq
- Market Cap
- LEO 362.5M
- NPCE 292.9M
- IPO Year
- LEO N/A
- NPCE 2021
- Fundamental
- Price
- LEO $6.19
- NPCE $9.82
- Analyst Decision
- LEO
- NPCE Strong Buy
- Analyst Count
- LEO 0
- NPCE 6
- Target Price
- LEO N/A
- NPCE $16.67
- AVG Volume (30 Days)
- LEO 200.2K
- NPCE 190.1K
- Earning Date
- LEO 01-01-0001
- NPCE 11-11-2025
- Dividend Yield
- LEO 4.01%
- NPCE N/A
- EPS Growth
- LEO N/A
- NPCE N/A
- EPS
- LEO 0.04
- NPCE N/A
- Revenue
- LEO N/A
- NPCE $88,570,000.00
- Revenue This Year
- LEO N/A
- NPCE $22.13
- Revenue Next Year
- LEO N/A
- NPCE $6.07
- P/E Ratio
- LEO $152.00
- NPCE N/A
- Revenue Growth
- LEO N/A
- NPCE 23.32
- 52 Week Low
- LEO $4.98
- NPCE $5.45
- 52 Week High
- LEO $6.50
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- LEO 75.21
- NPCE 58.26
- Support Level
- LEO $5.83
- NPCE $9.60
- Resistance Level
- LEO $6.20
- NPCE $10.12
- Average True Range (ATR)
- LEO 0.05
- NPCE 0.40
- MACD
- LEO 0.03
- NPCE 0.10
- Stochastic Oscillator
- LEO 92.31
- NPCE 74.46
About LEO BNY Mellon Strategic Municipals Inc.
BNY Mellon Strategic Municipals, Inc. is a diversified closed-end management investment company. The fund's investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. Its products are Equity and Fixed Income Mutual Funds, Retail Money Market Funds, Government/Treasury Money Market Funds, Institutional Money Market Funds, and others. BNY Mellon and its affiliates, including BNYM Investment Adviser, INA and others involved in the management, sales, investment activities, business operations or distribution of the Fund, are engaged in businesses and have interests other than that of managing the Fund.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.